Leave your feedback Share Copy URL https://ar-c.org/video/AXtfOLOm4QR.html Email Facebook Twitter LinkedIn Pinterest Tumblr Share on Facebook Share on Twitter FDA reverses course, will review Moderna’s new mRNA flu vaccine [h0nfKU6licy] Health Updated on August 06, 2026 EDT — Published on August 06, 2026 EDT Two weeks ago, the FDA took the rare step of refusing to accept Moderna’s application for its first mRNA flu vaccine. After meeting with the company, the agency has now agreed to review it. GosFBHt4LYn 7vtnupyTNdW bIxYyAP9hl9 EEI3aCv3E9s 7din6nxjqSG UYkhmJUVb17 acnlOg3zRMM
Two weeks ago, the FDA took the rare step of refusing to accept Moderna’s application for its first mRNA flu vaccine. After meeting with the company, the agency has now agreed to review it. GosFBHt4LYn 7vtnupyTNdW bIxYyAP9hl9 EEI3aCv3E9s 7din6nxjqSG UYkhmJUVb17 acnlOg3zRMM